Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 7, 2023
Ertapenem plus meropenem combination treatment in carbapenem-resistant Klebsiella pneumoniae bacteremia: an analysis of 53 casesUğur Önal, Deniz Akyol, Arda Kaya, et al.Diagnostic Microbiology and Infectious Disease|December 24, 2023
Impact of the empirical therapy timing on the clinical progress of septic shock patientsDeniz Akyol, İlkin Çankayalı, Murat Ersel, et al.Journal of Chemotherapy (Florence, Italy)|April 21, 2022
Carbapenem-resistant Gram-negative pathogens associated with septic shock: a review of 120 casesUğur Önal, Deniz Akyol, Merve Mert, et al.Mediterranean Journal of Hematology and Infectious Diseases|July 10, 2024
Importance of Source Control in the Subgroup of Intra-Abdominal Infections for Septic Shock Patients: Analysis of 390 CasesUğur Önal, Deniz Akyol Seyhan, Olcay Buse Ketenoğlu, et al.Journal of Infection in Developing Countries|March 6, 2026
Susceptibility of carbapenem-resistant Klebsiella pneumoniae in urinary tract infections: clinical efficacy of fosfomycinArda Kaya, Deniz Akyol-Seyhan, Seichan Chousein-Memetali, et al.BMC Infectious Diseases|September 28, 2023
Empirical cefepime+vancomycin versus ceftazidime+vancomycin versus meropenem+vancomycin in the treatment of healthcare-associated meningitis: results of the multicenter ephesus studyOguz Resat Sipahi, Deniz Akyol, Bahar Ormen, et al.The Journal of Infection|October 17, 2025
Risk factors for persistent candidemia and prognostic implications: Results from the ECMM Candida III studySarah Sedik, Matthias Egger, Stella Wolfgruber, et al.The Journal of Infection|July 18, 2024
Attributable mortality of candidemia - Results from the ECMM Candida III multinational European Observational Cohort StudyJon Salmanton-García, Oliver A Cornely, Jannik Stemler, et al.The American Journal of Gastroenterology|November 9, 2021
Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 StudyGiovanni Marasco, Cesare Cremon, Maria Raffaella Barbaro, et al.Gut|January 2, 2023
Post COVID-19 irritable bowel syndromeGiovanni Marasco, Cesare Cremon, Maria Raffaella Barbaro, et al.Pageof 3